@article{lekakis2024naturalhistmasld,
  title = {Natural history of metabolic dysfunction-associated steatotic liver disease},
  author = {Lekakis, V and Paptheodoridis, GV},
  journal = {European Journal of Internal Medicine},
  year = {2024},
  volume = {122},
  number = {3},
  pages = {3--10},
  doi = {10.1016/j.ejim.2023.11.005},
  tags = {prevalence, progression, mortality, profile},
  geography = {global}
}

@article{younossi2016globalnafld,
  title = {Global epidemiology of nonalcoholic fatty liver disease - Meta-analytic assessment of prevalence, incidence, and outcomes},
  author = {Younossi, Z and Koenig, A and Abdelatif, D and Fazel, Y and Henry, L and Wymer, M},
  journal = {Hepatology},
  year = {2016},
  volume = {64},
  number = {1},
  pages = {73--84},
  doi = {10.1002/hep.28431},
  tags = {prevalence, profile, progression, incidence},
  geography = {global, continents}
}

@article{hagstrom2024progressionmasld,
  title = {Natural history and progression of metabolic dysfunction-associated steatotic liver disease},
  author = {Hagström H and Shang Y and Hegmar H and Nasr P},
  journal = {Lancet Gastroenterology & Hepatology},
  year = {2024},
  volume = {9},
  number = {10},
  pages = {944--956},
  doi = {10.1016/S2468-1253(24)00193-6},
  tags = {progression, prevalence, profile},
  geography = {Sweden}
}

@article{younossi2023systematic,
  title = {The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) a systematic review},
  author = {Younossi, Z and  Golabi, P and  Paik, J and Henry, A and Van Dongen, C and Henry, L},
  journal = {Hepatology},
  year = {2023},
  volume = {77},
  number = {4},
  pages = {1335--1347},
  doi = {10.1097/HEP.0000000000000004},
  tags = {prevalence, mortality, incidence},
  geography = {global, continent}
}

@article{younossi2019globalhealth,
  title = {Non-alcoholic fatty liver disease - A global public health persepective},
  author = {Younossi, Z},
  journal = {Journal of Hepatology},
  year = {2019},
  volume = {70},
  number = {3},
  pages = {531--544},
  doi = {10.1016/j.jhep.2018.10.033},
  tags = {prevalence, incidence, profile},
  geography = {global, continent}
}

@article{alenezi2022ukprev,
  title = {The prevalence of non-alcoholic fatty liver disease in the United Kingdom - A systematic review and meta-analysis},
  author = {Alenezi, Y and Card, T and Morling, J and Harris, R},
  journal = {Journal of Hepatology},
  year = {2022},
  volume = {77},
  pages = {S145},
  doi = {10.1016/S0168-8278(22)00670-5},
  tags = {prevalence},
  geography = {UK}
}

@article{basu2022mgmt,
  title = {Nonalcoholic Fatty Liver Disease - Review of Management for Primary Care Providers},
  author = {Basu, R and Noureddin, M and Clark, J},
  journal = {Mayo Clinical Proceedings},
  year = {2022},
  volume = {97},
  number = {9},
  pages = {1700--1716},
  doi = {10.1016/j.mayocp.2022.04.005},
  tags = {prevalence, profile, subgroups, progression},
  geography = {USA}
}

@article{angulo2015fibrosis,
  title = {Liver Fibrosis, but no Other Histological Features, is Associated with Long-Term Outcomes of Patients with Nonalcoholic Fatty Liver Disease},
  author = {Angulo P and Kleiner, D and Dam-Larsen, S and Adams, L and Bjornsson, E and Charatcharoenwitthaya, P and Mills, P and Keach J, Lafferty, H, Stahler, A and Halifdadottir, S and Bendtsen, F},
  journal = {Gastroenterology},
  year = {2015},
  volume = {149},
  number = {2},
  pages = {289--397},
  doi = {10.1053/j.gastro.2015.04.043},
  tags = {subgroups},
  geography = {USA, Europe, Thailand}
}

@article{taylor2020fibrosisstage,
  title = {Association between Fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease - A systematic review and meta-analysis},
  author = {Rod S. Taylor and Rebecca J. Taylor and Sue Bayliss and Hannes Hagström and Patrik Nasr and Jorn M. Schattenberg and Masatoshi Ishigami and Hidenori Toyoda and Vincent {Wai-Sun Wong} and Noam Peleg and Amir Shlomai and Giada Sebastiani and Yuya Seko and Neeraj Bhala and Zobair M. Younossi and Quentin M. Anstee and Stuart McPherson and Philip N. Newsome},
  journal = {Gastroenterology},
  year = {2020},
  volume = {158},
  number = {6},
  pages = {1611--1625},
  doi = {10.1053/j.gastro.2020.01.043},
  tags = {subgroups, mortality},
  geography = {global}
}

@article{estes2018modelling,
  title = {Modelling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030},
  author = {C Estes and Q Anstee and MT Arias-Loste and H Bantel and S Bellentani and J Caballeria and M Colombo and A Craxi and J Crespo and CP Day and Y Eguichi and A Geier and LA Kondili and DC Kroy and JV Lazarus and R Loomba and MP Manns and G Marchesini and A Nakajima and F Negro and S Petta and V Ratziu and M Romero-Gomez and A Sanyal and JM Schattenburg and F Tacke and J Tanaka and C Trautwein and L Wei and S Zeuzem and H Razavi},
  journal = {Journal of Hepatology},
  year = {2018},
  volume = {69},
  number = {4},
  pages = {896-904},
  doi = {10.1016/j.jhep.2018.05.036},
  tags = {subgroups, progression},
  geography = {global, UK}
}

@article{singh2015progression,
  title = {Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis- A Systematic Review and Meta-analysis of Paired-Biopsy Studies},
  author = {S Singh and AM Allen and Z Wang and  LJ Prokop and MH Murad and R Loomba},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2015},
  volume = {13},
  number = {4},
  pages = {643--654},
  doi = {10.1016/j.cgh.2014.04.014},
  tags = {progression, subgroups},
  geography = {global}
}

@article{konyn2023mortality,
  title = {Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease},
  author = {P Konyn and A Ahmed and D Kim},
  journal = {Clinical and Molecular Hepatology},
  year = {2023},
  volume = {29},
  number = {Suppl},
  pages = {S43--S57},
  doi = {10.3350/cmh.2022.0351},
  tags = {mortality, profile},
  geography = {global}
}

@article{pustjens2024profile,
  title = {Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD},
  author = {J Pustjens and LA van Kleep and HLA Janssen and RJ de Knegt and WP Brouwer},
  journal = {JHEP Reports},
  year = {2024},
  volume = {6},
  number = {12},
  pages = {101193},
  doi = {10.1016/j.jhepr.2024.101193},
  tags = {profile, prevalence},
  geography = {USA}
}

@article{cho2023diabetes,
  author = {En Li Cho, Elina and Ang, Chong Zhe and Quek, Jingxuan and Fu, Clarissa Elysia and Lim, Lincoln Kai En and Heng, Zane En Qi and Tan, Darren Jun Hao and Lim, Wen Hui and Yong, Jie Ning and Zeng, Rebecca and Chee, Douglas and Nah, Benjamin and Lesmana, Cosmas Rinaldi Adithya and Bwa, Aung Hlaing and Win, Khin Maung and Faulkner, Claire and Aboona, Majd B and Lim, Mei Chin and Syn, Nicholas and Kulkarni, Anand V. and Suzuki, Hiroyuki and Takahashi, Hirokazu and Tamaki, Nobuharu and Wijarnpreecha, Karn and Huang, Daniel Q. and Muthiah, Mark and Ng, Cheng Han and Loomba, Rohit},
	title = {Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis},
	journal = {Gut},
	volume = {72},
	number = {11},
	pages = {2138--2148},
	year = {2023},
	doi = {10.1136/gutjnl-2023-330110},
	tags = {profile},
	geography = {global}
}

@article{simon2021mortality,
  author = {Simon, Tracey G and Roelstraete, Bjorn and Khalili, Hamed and Hagstr{\"o}m, Hannes and Ludvigsson, Jonas F},
  title = {Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort},
  journal = {Gut},
  volume = {70},
  number = {7},
  pages = {1375--1382},
  year = {2021},
  doi = {10.1136/gutjnl-2020-322786},
  tags = {mortality},
  geography = {Sweden}
}

@article{sripongpun2024mortality,
  author = {Pimsiri Sripongpun and Apichat Kaewdech and Prowpanga Udompap and W. Ray Kim},
  title = {Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score},
  journal = {JHEP Reports},
  volume = {6},
  number = {10},
  pages = {2589--5559},
  year = {2024},
  doi = {https://doi.org/10.1016/j.jhepr.2024.101127},
  tags = {mortality, profile},
  geography = {USA}
}

@article{owrangi2024cirrhosis,
  author = {Owrangi, Soroor and Paik, James M. and Golabi, Pegah and de Avila, Leyla and Hashida, Ryuki and Nader, Ariana and Paik, Annette and Henry, Linda and Younossi, Zobair M.},
  title = {Meta-Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease},
  journal = {Alimentary Pharmacology \& Therapeutics},
  volume = {61},
  number = {3},
  pages = {433-443},
  year = {2025},
  doi = {https://doi.org/10.1111/apt.18451},
  tags = {mortality, subgroups},
  geography = {global, europe}
}

@article{EASL2016,
  title = {{EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease}},
  author = {{European Association for the Study of the Liver (EASL)} and {European Association for the Study of Diabetes (EASD)} and {European Association for the Study of Obesity (EASO)}},
  journal = {Journal of Hepatology},
  volume = {64},
  number = {6},
  pages = {1388--1402},
  year = {2016},
  doi = {10.1016/j.jhep.2015.11.004},
  tags = {incidence},
  geography = {Global}
}

@article{economicimpactuk2018,
  title = {{Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018}},
  author = {A Morgan and S Hartmanis and E Tsochatzis and PN Newsome and SD Ryder and R Elliot and R Hall and V Higgins and G Stanley and S Cure and S Vasudevan and L Pezzullo},
  journal = {The European Journal of Health Economics},
  year = {2021},
  volume = {22},
  pages = {505--518},
  doi = {10.1007/s10198-020-01256-y},
  tags = {modelling, subgroups, diagnosis},
  geography = {UK}
}

@article{Schattenburg2021,
  author = {Schattenberg, Jörn M. and Lazarus, Jeffrey V. and Newsome, Philip N. and Serfaty, Lawrence and Aghemo,      Alessio and Augustin, Salvador and Tsochatzis, Emmanuel and de Ledinghen, Victor and Bugianesi, Elisabetta and        Romero-Gomez, Manuel and Bantel, Heike and Ryder, Stephen D. and Boursier, Jerome and Leroy, Vincent and Crespo,      Javier and Castera, Laurent and Floros, Lefteris and Atella, Vincenzo and Mestre-Ferrandiz, Jorge and Elliott,        Rachel and Kautz, Achim and Morgan, Alice and Hartmanis, Sally and Vasudevan, Sharad and Pezzullo, Lynne and          Trylesinski, Aldo and Cure, Sandrine and Higgins, Victoria and Ratziu, Vlad},
  title = {{Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries    in 2018: A cost-of-illness analysis}},
  journal = {Liver International},
  year = {2021},
  volume = {41},
  number = {6},
  pages = {1227-1242},
  doi = {https://doi.org/10.1111/liv.14825},
  tags = {modelling, subgroups, diagnosis},
  geography = {UK, Europe}
}

@article{Rotterdam2016,
  author = {Edith M Koehler, Elisabeth P C Plompen, Jeoffrey N L Schouten, Bettina E Hansen, Sarwa Darwish Murad, Pavel Taimr, Frank W G Leebeek, Albert Hofman, Bruno H Stricker, Laurent Castera, Harry L A Janssen},
  title = {{Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study}},
  journal = {Hepatology},
  year = {2016},
  volume = {63},
  number = {1},
  pages = {138-147}, 
  doi = {10.1002/hep.27981}, 
  tags = {diabetes}, 
  geography = {Europe}
}

@article{Mansour2021,
  author = {Dina Mansour, Allison Grapes, Marc Herscovitz, Paul Cassidy, Jonathan Vernazza,
Andrea Broad, Quentin M. Anstee, Stuart McPherson},
  title = {{Embedding assessment of liver fibrosis into routine diabetic review in primary care}},
  journal = {JHEP Reports},
  year = {2021},
  volume = {3},
  number = {4},
  pages = {1-14},
  doi = {10.1016/j.jhepr.2021.100293}, 
  tags = {diabetes, pathways}, 
  geography = {UK, USA}
}

@article{Koo2021,
  author = {Sara Koo, Linda Sharp, Mark Hull, Steven Rushton, Laura J Neilson , The OSCAR study team, Stuart McPherson, Colin J Rees},
  title = {{Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopy}},
  journal = {BMJ Open Gastroenterology},
  year = {2021},
  volume = {8},
  number = {1},
  pages = {1-7},
  doi = {10.1136/bmjgast-2021-000638},
  tags {colonoscopy, prevelance, obesity},
  geography = {Europe, Asia, UK}
  }
